Visomitin is primarily used in ophthalmology for the treatment of cataracts and other age-related eye conditions. It functions as a mitochondria-targeted antioxidant, helping to protect lens cells from oxidative stress and slow down the progression of lens opacity. The compound supports mitochondrial function in eye tissues, which can improve cellular energy production and reduce damage caused by free radicals. It is commonly administered as eye drops, allowing direct delivery to the affected area. Visomitin is also studied for its potential in improving visual function and delaying the need for surgical intervention in cataract patients. Additionally, it may help alleviate symptoms of eye fatigue and dryness, making it useful in managing general ocular discomfort associated with aging or prolonged screen use.